Peripheral neuropathy seems to be a potential adverse effect of rapid significant weight loss, including with GLP-1 receptor agonists. Have you encountered this much and how does it influence your use of GLP-1s if at all?

Have you diagnosed new or worsening peripheral neuropathy in your patients after starting a GLP-1a?

• Yes, frequently
• Yes, but infrequently
• Yes, but generally in my older patients
• No
• No, but I don’t prescribe many of these medications in my patient population
• Other